Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.
about
Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in RatsAngiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysmsG-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure.Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis.Therapeutic uses for Angiotensin-(1-7).Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning.Multiple roles of angiotensin in colorectal cancer.CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression.Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension.AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma.Effects of angiotensin-converting enzyme inhibitory peptide LAP on vascular remodeling.The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.Expression of the Mas receptor is upregulated in skeletal muscle wasting.
P2860
Q28546739-E0E8F285-03C2-4BB1-B5E6-058E75907806Q34606642-FC8924CB-BB4E-49A3-B7F2-3786FAFD3244Q35089791-E21FC875-D15A-4AEE-80CE-E71718883D94Q37085063-728BB67E-4833-4024-969D-27847C3A1E40Q37416298-34CAFD9C-AFDA-4EE7-B44E-AE7C06191BCDQ38207841-2D0CC091-70FB-477F-87AC-FD333B068E16Q38217456-D8511F68-DF9E-4415-A849-19A3CE10E309Q38317550-CAA5DEC4-B9D8-449F-AF23-92F6706CC458Q38819427-04E53180-6F9E-4E0D-81B4-A2B2CD6A2433Q40373369-FBA982D6-44DA-4CD0-907C-85485EF6A807Q42104181-C53C5460-1012-4276-96E7-2F6ACFC46F0FQ42316580-B89F74B4-5063-40E2-BC8F-683AFBB7F620Q42380125-302AF497-011C-44AE-AC0F-BD4E5DF1F69DQ42686839-8074B888-73CB-433C-9190-51E70D0AA401Q44213264-C9E97CF3-5F6F-4141-8D28-96FAFF0922E0Q46924901-58F604F9-3FEA-4365-9812-9DDBA0C57367Q54192199-3122CA08-6BAD-4C81-81D7-E9B3A97767C3
P2860
Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic targeting of the a ...... ensin system: a patent review.
@en
type
label
Therapeutic targeting of the a ...... ensin system: a patent review.
@en
prefLabel
Therapeutic targeting of the a ...... ensin system: a patent review.
@en
P2860
P1476
Therapeutic targeting of the a ...... ensin system: a patent review.
@en
P2093
Anderson J Ferreira
Robson A S Santos
P2860
P304
P356
10.1517/13543776.2012.682572
P407
P577
2012-04-18T00:00:00Z